spacer
home > directory > TwistDx Limited
PHARMACEUTICAL INDUSTRY DIRECTORY

TwistDx Limited

TwistDx Limited

TwistDx Limited (formerly ASM Scientific Ltd) is a biotechnology company founded in 1999, and became part of the Alere Group in March 2010. TwistDx developed a breakthrough isothermal DNA amplification technology called Recombinase Polymerase Amplification (RPA). RPA is a revolutionary alternative to Polymerase Chain Reaction (PCR) and is positioned to become the DNA-based diagnostic platform of the future with wide ranging applications in a number of fields, including medical diagnostics, veterinary medicine, industrial applications, food testing, agriculture, public health, biosecurity and environmental sensing.

In 2009 TwistDx launched the TwistAmp ® product range, and in doing so the world’s first DNA amplification kit using RPA. Included within this TwistAmp ® product range are kits for TwistAmp ® Basic (gel electrophoresis detection, cloning and basic isothermal amplification), TwistAmp ® exo and fpg (real-time fluorescent detection) and the TwistAmp ® nfo (lateral flow detection). Already researchers have published peer-reviewed articles showing how TwistAmp ® kits can detect HIV-1 proviral DNA (Boyle DS et al. mBio 4(2):e00135-13) and a panel of biothreat agents including Bacillus anthracis and the Ebolla virus (Euler et al J Clin Microbiol. 2013 51(4):1110-7) and how RPA tests can be performed using a simple paper and plastic device (Rohrman et al Lab Chip 2012 Jun 26) or a slip-chip for digital quantification (Shen et al Anal Chem. 2011 May 1;83(9):3533-40).

To further enable the adoption of RPA, TwistDx launched the Twista ® a portable, real-time fluorometer. The Twista ® is an easy-to-use, cheaper alternative to real-time thermal cyclers and plate readers for running RPA reactions.

TwistDx’s Novel Test to Detect MRSA was selected as a Winner in the NHS Smart Solutions Programme in 2009 and they also announced a collaboration with Monsanto to begin field trials of rapid diagnostic tests for more efficient delivery of biotech crops.

In September 2010 TwistDx expanded and opened the production site based on the Cambridge Science Park. The Babraham Research Campus site is now used specifically for R&D.

In 2012 TwistDx launched TwistAmp ® exo RT (for RNA amplification and detection) and kits specifically designed for the detection of the Salmonella enterica target gene INVA - TwistFlow ® Salmonella (lateral flow detection) and TwistGlow ® Salmonella (fluorescent detection).

phone 01223 496700
email c.smith@twistdx.co.uk
web www.twistdx.co.uk
email TwistDx Limited, Minerva Building, Babraham Research Campus, Babraham, Cambridge, CB22 3AT
 
spacer

Member login

E-mail address:

Password:
Remember me

Industry Events

BIO-Europe Digital

26-29 October 2020, Digitally delivered

Global connections are more important than ever. With the same powerful one-to-one partnering and valuable content, BIO-Europe Digital continues to help you drive your life science partnering forward.
More info >>

 
News and Press Releases

Hope for a new treatment for the autoimmune neuromuscular disease Myasthenia Gravis (MG)

- The biotech companies 3P Biopharmaceuticals and Toleranzia collaborate for that MG treatment - MG is an orphan disease which has a major unmet medical need and a large market potential - The drug candidate,TOL2, has already achieved several positive preclinical results
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement